Forward Deployed Engineers, or FDEs, have become one of the fastest-growing AI job roles worldwide. From OpenAI to Cognizant, ...

Shortly after Freddie was born in April 2025, he was diagnosed with retinoblastoma, a rare form of eye cancer. It was spotted early and treated promptly, which means he has a much better chance of ...

Gov. Ron DeSantis has laid out his decisions on Florida’s new budget, including line-item vetoes and what those cuts mean for programs around the state. Below is the full veto list so readers can see, ...

BEIJING, June 29 (Reuters) - China added 20 Japanese entities on Monday to its export control list for dual-use items, preventing Chinese firms from selling to them without prior approval, citing ...

More than half of patients diagnosed with binge eating disorder and one third of patients with atypical anorexia nervosa reported having used GLP-1 receptor agonists, according to a recent study ...

Doctors using new technology to help treat patients Imagine knowing you're at risk for a major illness years before you ever show symptoms. A healthcare company Fountain Life is using artificial ...

White House officials on Tuesday shot down a report speculating President Trump gained access to the retatrutide weight loss drug under the Food and Drug Administration’s (FDA) “compassionate use ...

Questions are swirling over Donald Trump’s health after a bombshell report revealed a mystery man was getting unprecedented access to a weight-loss drug. A special 79-year-old man has received ...

A special 79-year-old man has received unparalleled access to Eli Lilly's obesity drug. Millions of Americans are eagerly awaiting access to retatrutide, a powerful new drug from the pharmaceutical ...

In an extremely odd case, a single 79-year-old patient was granted early access to Eli Lilly’s powerful, still-experimental obesity drug retatrutide through the Food and Drug Administration’s ...

Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.